Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages
- PMID: 19033389
- DOI: 10.1242/jcs.032763
Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages
Abstract
The class IA isoforms of phosphoinositide 3-kinase (p110alpha, p110beta and p110delta) often have non-redundant functions in a given cell type. However, for reasons that are unclear, the role of a specific PI3K isoform can vary between cell types. Here, we compare the relative contributions of PI3K isoforms in primary and immortalised macrophages. In primary macrophages stimulated with the tyrosine kinase ligand colony-stimulating factor 1 (CSF1), all class IA PI3K isoforms participate in the regulation of Rac1, whereas p110delta selectively controls the activities of Akt, RhoA and PTEN, in addition to controlling proliferation and chemotaxis. The prominent role of p110delta in these cells correlates with it being the main PI3K isoform that is recruited to the activated CSF1 receptor (CSF1R). In immortalised BAC1.2F5 macrophages, however, the CSF1R also engages p110alpha, which takes up a more prominent role in CSF1R signalling, in processes including Akt phosphorylation and regulation of DNA synthesis. Cell migration, however, remains dependent mainly on p110delta. In other immortalised macrophage cell lines, such as IC-21 and J774.2, p110alpha also becomes more prominently involved in CSF1-induced Akt phosphorylation, at the expense of p110delta.These data show that PI3K isoforms can be differentially regulated in distinct cellular contexts, with the dominant role of the p110delta isoform in Akt phosphorylation and proliferation being lost upon cell immortalisation. These findings suggest that p110delta-selective PI3K inhibitors may be more effective in inflammation than in cancer.
Similar articles
-
The p110delta isoform of PI 3-kinase negatively controls RhoA and PTEN.EMBO J. 2007 Jul 11;26(13):3050-61. doi: 10.1038/sj.emboj.7601763. Epub 2007 Jun 21. EMBO J. 2007. PMID: 17581634 Free PMC article.
-
Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.FEBS J. 2013 Nov;280(21):5228-36. doi: 10.1111/febs.12316. Epub 2013 Jun 5. FEBS J. 2013. PMID: 23648053 Free PMC article.
-
The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8292-7. doi: 10.1073/pnas.0707761105. Epub 2008 Jun 10. Proc Natl Acad Sci U S A. 2008. PMID: 18544649 Free PMC article.
-
Recent patents of gene sequences relative to the phosphatidylinositol 3-kinase/Akt pathway and their relevance to drug discovery.Recent Pat DNA Gene Seq. 2007;1(1):9-23. doi: 10.2174/187221507779814461. Recent Pat DNA Gene Seq. 2007. PMID: 19075915 Review.
-
Targeting phosphoinositide 3-kinase: moving towards therapy.Biochim Biophys Acta. 2008 Jan;1784(1):159-85. doi: 10.1016/j.bbapap.2007.10.003. Epub 2007 Oct 12. Biochim Biophys Acta. 2008. PMID: 17997386 Review.
Cited by
-
PI3K signaling promotes formation of lipid-laden foamy macrophages at the spinal cord injury site.Neurobiol Dis. 2024 Jan;190:106370. doi: 10.1016/j.nbd.2023.106370. Epub 2023 Dec 2. Neurobiol Dis. 2024. PMID: 38049013 Free PMC article.
-
Inhibition of Vps34 and p110δ PI3K Impairs Migration, Invasion and Three-Dimensional Spheroid Growth in Breast Cancer Cells.Int J Mol Sci. 2022 Aug 12;23(16):9008. doi: 10.3390/ijms23169008. Int J Mol Sci. 2022. PMID: 36012280 Free PMC article.
-
Human Cytomegalovirus Mediates Unique Monocyte-to-Macrophage Differentiation through the PI3K/SHIP1/Akt Signaling Network.Viruses. 2020 Jun 17;12(6):652. doi: 10.3390/v12060652. Viruses. 2020. PMID: 32560319 Free PMC article.
-
Human Cytomegalovirus Glycoprotein-Initiated Signaling Mediates the Aberrant Activation of Akt.J Virol. 2020 Jul 30;94(16):e00167-20. doi: 10.1128/JVI.00167-20. Print 2020 Jul 30. J Virol. 2020. PMID: 32493823 Free PMC article.
-
Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC).Cancers Head Neck. 2018 Jun 4;3:3. doi: 10.1186/s41199-018-0030-z. eCollection 2018. Cancers Head Neck. 2018. PMID: 31093356 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
- BB/C505659/2/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- G0800914/MRC_/Medical Research Council/United Kingdom
- BB/C505659/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- G0700755/MRC_/Medical Research Council/United Kingdom
- BB/E528936/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous